Governance

Baroness Sugg became Chair of the Board of Trustees in March 2022. She is a member of the UK House of Lords, where her main focus is on international development, foreign affairs and gender equality. She was Minister for Sustainable Development at the Foreign, Commonwealth and Development Office, previously serving as Minister at the Department for International Development from April 2019. Baroness Sugg was the UK's first Special Envoy for Girls' Education, and her ministerial portfolio included gender equality, sexual and reproductive health and rights, education, children and youth, as well as inclusive societies.

She resigned from her position in November 2020 following the decision to cut spending on International Development from 0.7% of Gross National Income.

She is the Vice-Chair of the All Party Parliamentary Group on Malaria & Tropical Diseases.

Prior to joining the House of Lords, she served for six years as Director of Operations and Campaigns at 10 Downing Street under Prime Minister David Cameron.

Stewart serves as the Malaria No More UK Treasurer and is Head of London for BHP, a multinational natural resources company. In over two decades at BHP, he has held senior roles spanning finance, risk, marketing and business development. He has led teams and projects across multiple commodities and regions including Australia, Europe, West Africa and Singapore.

Retiring in 2019 after a 40 year career, Norman has worked providing professional accounting and consulting services to the Government, state-owned enterprises, private organisations, and development institutions in Zambia. He also worked at Anglo American Plc in South Africa, at Chief Executive Officer and Chief Financial Officer of major subsidiaries or business units. He is Chairman of Anglo American Platinum Ltd and Zambia Sugar Plc, and sits on the Board of the South African Reserve Bank.

Dr David Reddy, PhD, is CEO of Medicines for Malaria Venture (MMV). MMV is a not-for-profit research foundation that, together with its partners, has brought forward 13 new antimalarial drugs to malaria-endemic countries, saving an estimated 2 million lives to date. In addition, MMV has broadened the global malaria medicine portfolio and manages, with its partners, 65 projects. David has 26 years of experience in the development and commercialization of medicines for the treatment of infectious diseases. He is also a Board member of the Coalition for Epidemic Preparedness Innovations (CEPI), of the RBM Partnership to End Malaria, as well as Malaria No More UK.

Dr Eva Thorne directs policy and innovations for the Tony Blair Institute for Global Change, leading a team that focuses on politically actionable research and prototyping on Africa and the 4th industrial revolution, digitalisation for inclusive economic growth, and innovative partnerships across governments and the private sector. Eva has a background of experience working in developing countries with civil society groups, public sector institutions and NGOs on social, environmental and governance issues. She has also worked with African parliamentarians on revenue management and natural resource governance. Eva holds a doctorate in political science from the Massachusetts Institute of Technology and an undergraduate degree in history from Harvard University.

Sarah is Global Brand Director for Swedish multinational hygiene business Essity, responsible for driving innovation and sustainability across all markets. She is the former CEO of advertising and communications agency, AMV BBDO, an Agency she took to the top of the leagues creatively. Across a 20 year career in marketing communications Sarah has partnered with global and domestic organisations in a variety of sectors and international geographies to drive business growth, organisational transformation and cultural inclusion.

Founder and Managing Partner of Open Squares Africa. Feyi consults for multi-national and indigenous firms on how to win in the African market-place. He is the Former Director of Insight Publicis, the largest advertising agency in West Africa, and author of 'The Villager: How Africans Consume Brands'.

Geoff joined the Wellcome Trust’s investment team in 1998 and since then has been responsible for Wellcome’s investments in venture capital funds globally, as well as the equity long/short hedge fund exposure. In all, this comprises around a quarter of Wellcome’s investment portfolio.